文献速递眼底病与葡萄膜炎

年龄相关性眼病研究2中与年龄相关性黄斑变性相关的外周视网膜改变:年龄相关性眼病研究2报告第12号

Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.
PubMed 文献 · Ophthalmology · 2017-01-12

本研究为横断面评估,比较年龄相关性眼病研究2(AREDS2)中至少中等程度年龄相关性黄斑变性(AMD)患者与无中等程度年龄相关性改变(玻璃膜疣)对照者的外周视网膜改变发生率。结果显示AMD眼外周视网膜改变较对照眼更常见,玻璃膜疣在AMD眼中多数可见于中周部和远周部,而色素改变和晚期AMD特征较少见。作者认为AMD可能不仅是「黄斑」疾病,而是累及整个视网膜。

要点

  • AMD眼外周玻璃膜疣检出率高于对照眼,中周部和远周部均如此。
  • 老年性网状色素改变在AMD眼2区为48%,对照眼为16%。
  • AMD眼外周也可见新生血管和地图样萎缩,但比例较低。

核心结论

  • 外周视网膜改变在AMD眼中比对照眼更普遍。
  • 玻璃膜疣在AMD眼的中周部和远周部多数可见,而色素改变和晚期AMD特征较少见。
  • AMD可能不仅是「黄斑」疾病,而是累及整个视网膜。
  • 未来关于AMD外周改变及其对视觉功能影响的纵向研究可能有助于理解AMD发病机制。

研究设计与样本

  • 横断面评估,纳入AREDS2临床患者及一项前瞻性研究的参与者。
  • 共484例(951眼)至少中等程度AMD的AREDS2参与者(病例)和89例(163眼)无AMD对照者具有可分级彩色和眼底自发荧光(FAF)图像。
  • 使用Optos 200 Tx超广角设备以黄斑为中心并向上、向下引导拍摄200°假彩色和FAF图像,拼接图像在阅片中心分为3区(1区[后极部]、2区[中周部]、3区[远周部])进行分级。

主要发现

  • 在2区和3区,病例眼新生血管和地图样萎缩(GA)存在率分别为0.4%至6%,对照眼GA存在率为1%。
  • 玻璃膜疣在病例眼2区、3区上方和3区下方检出率分别为97%、78%和64%,对照眼分别为48%、21%和9%(所有P < 0.001)。
  • 外周网状假性玻璃膜疣见于15%的病例眼。
  • 老年性网状色素改变是2区主要外周改变,病例眼为48%,对照眼为16%(P < 0.001)。
  • 非网状色素改变在外周较后极部少见(46% vs. 76%),在对照眼中可忽略不计。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare rates of peripheral retinal changes in Age-Related Eye Disease Study 2 (AREDS2) participants with at least intermediate age-related macular degeneration (AMD) with control subjects without intermediate age-related changes (large drusen). DESIGN: Cross-sectional evaluation of clinic-based patients enrolled in AREDS2 and a prospective study. PARTICIPANTS: Participants from prospective studies. METHODS: The 200° pseudocolor and fundus autofluorescence (FAF) images were captured on the Optos 200 Tx Ultrawide-field device (Optos, Dunfermline, Scotland) by centering on the fovea and then steering superiorly and inferiorly. The montaged images were graded at a reading center with the images divided into 3 zones (zone 1 [posterior pole], zone 2 [midperiphery], and zone 3 [far periphery]) to document the presence of peripheral lesions. MAIN OUTCOME MEASURES: Peripheral retinal lesions: drusen, hypopigmentary/hyperpigmentary changes, reticular pseudodrusen, senile reticular pigmentary changes, cobblestone degeneration, and FAF abnormalities. RESULTS: A total of 484 (951 eyes) AREDS2 participants with AMD (cases) and 89 (163 eyes) controls without AMD had gradable color and FAF images. In zones 2 and 3, neovascularization and geographic atrophy (GA) were present, ranging from 0.4% to 6% in eyes of cases, respectively, and GA was present in 1% of eyes of controls. Drusen were detected in 97%, 78%, and 64% of eyes of cases and 48%, 21%, and 9% of eyes of controls in zones 2 and 3 superior and 3 inferior, respectively (P < 0.001 for all). Peripheral reticular pseudodrusen were seen in 15%. Senile reticular pigmentary change was the predominant peripheral change seen in 48% of cases and 16% of controls in zone 2 (P < 0.001). Nonreticular pigment changes were less frequent in the periphery than in the posterior pole (46% vs. 76%) and negligible in controls. CONCLUSIONS: Peripheral retinal changes are more prevalent in eyes with AMD than in control eyes. Drusen are seen in a majority of eyes with AMD in both the mid and far periphery, whereas pigment changes and features of advanced AMD are less frequent. Age-related macular degeneration may be more than a "macular" condition but one that involves the entire retina. Future longitudinal studies of peripheral changes in AMD and their impact on visual function may contribute to understanding AMD pathogenesis.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Domalpally A, Clemons TE, Danis RP, et al. Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group. Ophthalmology. 2017. PMID: 28089680. doi:10.1016/j.ophtha.2016.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。